The effect of therapeutic drug monitoring of risperidone and aripiprazole on weight gain in children and adolescents: the space 2: star (trial) protocol of an insternational multicentre randomised controlled trial

HIGHLIGHTS

  • who: Rebecca A. Hermans from the Department of Child and Adolescent Psychiatry/Psychology, Erasmus University Medical Center, CB Rotterdam, the Netherlands have published the research: The effect of therapeutic drug monitoring of risperidone and aripiprazole on weight gain in children and adolescents: the SPACe 2: STAR (trial) protocol of an insternational multicentre randomised controlled trial, in the Journal: (JOURNAL) of 18/08/2022
  • what: The trial SPACe 2: STAR is designed as a follow-up study in which the authors aim to research whether therapeutic drug monitoring in clinical practice can prevent severe weight gain . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?